+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
From
From
Ulcerative Colitis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Ulcerative Colitis Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 181 Pages
  • Global
From
Cell Therapy Clinical Activity and Process Automation - Product Thumbnail Image

Cell Therapy Clinical Activity and Process Automation

  • Report
  • July 2023
  • 100 Pages
  • Global
From
From
Rare Hemophilia Factors Market 2024-2028 - Product Thumbnail Image

Rare Hemophilia Factors Market 2024-2028

  • Report
  • July 2024
  • 142 Pages
  • Global
From
From
US Bispecific Antibodies Market & Clinical Pipeline Insight 2028 - Product Thumbnail Image

US Bispecific Antibodies Market & Clinical Pipeline Insight 2028

  • Drug Pipelines
  • August 2023
  • 580 Pages
  • United States
From
Companion Diagnostics (CDx) Market Report 2024-2034 - Product Thumbnail Image

Companion Diagnostics (CDx) Market Report 2024-2034

  • Report
  • January 2024
  • 307 Pages
  • Global
From
Oncology Markets for Tyrokinse Kinase Inhibitors - Product Thumbnail Image

Oncology Markets for Tyrokinse Kinase Inhibitors

  • Report
  • October 2021
  • 137 Pages
  • Global
From
Loading Indicator